Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
Europe’s equity capital markets bankers are expressing concern that deals they’re working on now will be damaged if the re-opening of the continent’s economies is reversed in the autumn. But new research on Covid-19 and last year’s pattern of infections shows they’re right to be nervous. -
LinkDoc Technology, a cancer-focused medical data company, has filed paperwork for a $100m offering of American depository shares (ADS).
-
A group of Suriname’s bondholders on Monday followed through on their threat to cancel the payment relief that they had offered the sovereign, effectively pushing the government into technical default. But the move only supports expectations that restructuring negotiations will be lengthy and fraught.
-
Two European animal healthcare companies have announced their intention to float in recent days. Bankers hope that the fast growing sector will offer something different in a crowded pipeline of new stockmarket listings in the region.
-
Gushengtang, a Chinese fintech-linked healthcare company, is plotting a listing in Hong Kong, riding on the strong positive sentiment among investors for companies in this industry.
-
Shanghai MicroPort MedBot (Group) Co, which designs and develops surgical robots, is getting ready to list on the Hong Kong Stock Exchange.
